dc.description.abstract | Research Objectives:
The objectives of this research were to analyze and to explore the catheterization examinations or treatments of medical resources utilization, mortality rate and return rate among with different hospital groups. The essential factors of medical resource utilization and medical quality were included: (1) General medical payment, (2) the length of stay, (3) mortality rate, and (4) the return rate of catheterization. To approach the research objectives, one makes the following three hypotheses under controlling other related factors. The hypotheses were proceeded (1) different hospital groups factors affect the outcomes on catheterization examinations or treatments of medical resources utilization (General medical payment/the length of stay), (2) different hospital groups factors result in different mortality rate outcomes on catheterization examinations or treatments, (3) different hospital groups factors influence the patients return catheterization rate on catheterization examinations or treatments.
Method:
The cross-sectional research analysis was conducted by adopting the selective National Health Insurance data of 83,547 cases (72,325 case payment, 11,222 non-case payment) from 2000 to 2002.
Results:
1.The impacts of different hospital groups affect the outcomes on catheterization examinations or treatments of medical resources utilization (General medical payment/the length of stay). The highest Mean value of General medical payment on catheterization examinations declare are attributed to Non-profit Metropolitan Hospital. Moreover, in terms of catheterization treatments, the highest of General Medical payment s are attributed to Non-profit Metropolitan Hospitals、Public Medical Centers、Non-Profit Medical Centers respectively.
2.The means o f the length of stay on various case payment items in multiple regression model are all shown significant(p<.0001). However, considering catheterization treatments, one found there were merely the Private Metropolitan Hospitals and Public Medical Centers (Reference Group) showed significant(p<.0001), meanwhile, the length of stay are shown significant decline as well. Concerning the means of the length of stay from high to low are ranked as Non-Profit Medical Centers、Public Medical Centers、Public Metropolitan Hospitals、Non-profit Metropolitan Hospital、Private Metropolitan Hospitals in order.
3.The mortality rates on catheterization examinations or treatments in different hospital groups are shown significant (p=0.0003). Two situations are discussed. There is no significant of 30-day mortality rate in the case payment items among with different hospital groups. On the other hand, there is significant (p<0.01) in the non-case payment. Accordingly, the mortality rate of Private Metropolitan Hospitals was 3.62%, which was 441% higher by comparison Public Metropolitan Hospitals (0.82%). In comparison with 30-day mortality rate or above 30-day mortality rate, the mortality rate of Private Metropolitan Hospitals was 209% higher than Public Medical Centers (Reference Group), and the result showed significant (p=0.0002) as well.
4.The results of this research revealed that different hospital groups indeed affected patients return rate on catheterization examinations or treatments. Accordingly, the lowest return rate of Non-Profit Medical Centers was 0.90%, and the highest return rate of Non-profit Metropolitan Hospital was 2.20%.
Suggestions:
A. To public health policy makers
1.The public health bureau needs establish strictly investigate system and penalty stipulation for guiding hospitals to declare in accordance with rules.
2.The public health bureau needs stipulate basic training and access criterion to evaluate on-training physicians to secure patients health.
B. To medical institute manager
1.The hospitals need provide well-training physicians.
2.The hospitals need monitor the quality of low-operation physicians to raise the medical care standard.
3.The hospitals should cooperate with professional to observe the effects of treatments and prevent any harmful complication from being occurred.
C.To further researchers
In this study, one can not obtain the detail information of severity of patients’ heart blood vessel blocked in National Health Insurance database, consequently, it needs access by Chart-review studies. Thus, one suggests a well-understanding anamnesis needs well-training professional groups to access and to explain by applying double-blinded studies model to improve the further research result accurately. | en |
dc.relation.reference | 參考文獻
中文部份
林小嫻:「國民醫療保健支出」,衛生統計,1995。
林小嫻:「台灣地區國民醫療保險之初級及其財源與配置」,中央經濟研究所,1993。
http://www.doh.gov.tw/statistic/醫療統計年報/93.htm
行政院衛生署,2005衛生統計
中央健康保險局:全民健康保險醫療費用支附標準(上、中冊),2004。
中央健康保險局:全民健康保險統計,2000~2002
藍忠孚及DRGs 研究群:全民健康保險診療報酬預估支付制度之研究。行政院衛生署委託(五年)研究計劃,1993-1997。
莊逸洲:前瞻性支付制度之醫療管理模式建立與實証。台中:中國醫藥學院醫務管理研究所碩士論文,1995。
陳怡秀:自然生產論病例計酬對醫療資源耗用之影響:以三家醫學中心為例。台北:國立台灣大學公共衛生研究 所碩士論文,1996。
陳佳琪:健保論病例計酬門診手術與住院手術醫療資源耗用分析—以疝氣修補術為例。台中:私立中國醫藥學院醫務管理學研究所碩士論文,1999。
黃三桂:論病例計酬制度實施前後對住院日數及醫療費用之影響:以痔瘡併肛門廔管切除術為例,台北:國立陽明大學醫務管理研究所碩士論文,1999。
黃勝雄:論病例計酬實施前後對醫療資源利用之影響-以某區域醫院閉鎖性骨折開放性復位術為例。台中:中國醫藥學院醫務管理研究所碩士論文,2000。
吳寶榮、顧長生、林少琳:冠狀動脈疾病之侵襲性療法-PTCA與CABG 的比較。臨床醫學第三十八卷第一期;38:63-70,1996。
中央健康保險局:全民健康保險醫療費用支付標準表。臺北:中央健康保險局,2005。
中央健康保險局:全民健康保險論病例計酬支付作業要點。臺北:中央健康保險局,2005
中央健康保險局臺北分局:http://www.nhitb.gov.tw/xhospital/default.asp,2004。
王淑美:全膝關節置換術論病例計酬醫療資源耗用分析-以北部某醫學中心為例。台北:國立陽明大學醫務管理研究所碩士論文,2002。
于美德:心導管檢查醫療資源耗用分析。台北:國立陽明大學醫務管理研究所碩士論文,2002。
賴珊珊:接受不同經皮冠狀動脈介入性治療術病患之處置後三年醫療資源使用以及療效之探討。高雄:高雄醫學大學公共衛生學研究所碩士論文,2004。
張崴棣:醫療服務量與醫療品質關聯性之探討-以經皮冠狀動脈擴張術為例。高雄:高雄醫學大學公共衛生學研究所碩士論文,2004。
吳榮州:某區域醫院冠狀動脈疾病以經皮冠狀動脈氣球擴張術治療與支架治療之成本效果分析。高雄:高雄醫學大學公共衛生學研究所碩士論文,2004。
張樹棠:健保論病例計酬制度實施前後非論病例計酬案件之醫療資源耗用分析—以某醫學中心缺血性心臟病為例。台北:國立陽明大學醫務管理研究所碩士論文,2002。
行政院衛生署統計資料:http://www.doh.gov.tw/statistic/data/國民醫療保健支出/91/91 提要分析.doc,2002。
李玉春:全民健康保險住院論病例計酬制對醫院醫療行為之影響。臺北:行政院衛生署委託計劃,1996。
李玉彝:年齡與醫療保健費用支出的關係-家戶模型的分析與應用。嘉義:中正大學社會福利研究所碩士論文,1994。
李芳年:急診病人的資源耗用-以台北某區域教學醫院為例。台北:國立陽明大學醫管所碩士論文,2000。
吳肖琪:健康保險與醫療網區域資源對醫療利用之影響。台北:國立台灣大學公共衛生研究所博士論文,1991。
陳音潔:病患多次利用急診醫療之影響因素探討-以中部某醫學中心為例。台中:中國醫藥學院醫務管理研究所,2002。
陳俊全:台灣地區老年健康狀況與醫療費用之長期推估。嘉義:中正大學社會福利研究所碩士論文,1997。
張鴻仁:全民健康保險醫療費用支付制度之研究。臺北:行政院經建會委託計劃,1990。
曾億郎:全民健保論病例計酬制實施對剖腹產醫療資源耗用影響之研究。臺北:長庚大學管理學研究所醫院管理組碩士論文,1999。
黃俊煌:健保三階段支付制度變遷對痔瘡等六種疾病住院日及費用影響之研究。臺北:國立臺灣大學醫療機構管理研究所,1998。
蔡文惠:全民健康保險北區分局糖尿病人醫療利用及照護結果。臺北:國立陽明大學醫務管理研究所碩士論文,1999。
蔡依珍、黃偉堯:醫院對診斷關聯群之因應行為-以美國為例。醫院雜誌 2004; 37(3):23-31。
韓揆:台灣論病例計酬之實施及其變革展望。醫院 2002; 35(2): 15-27。
藍忠孚:勞保實施診斷關係群制度之研究(上冊)。臺北:行政院衛勞工委員會委託計劃,1990。
中央健康保險局:全民健康保險醫療費用支付標準,2002。
王石補:台灣安置冠狀動脈支架的經驗 秀傳醫學雜誌,1(1),1-3,1998。
江儀輝、李篤宜、李仁忠、程俊傑:冠狀動脈氣球擴張術及血管支架法之介紹與探討 中華放射線技術學雜誌,21(1),45-49,1997。
周友三、吳再成:經皮導管冠狀動脈管內整形術•當代醫學,10(1),62-4,1983。
柯文欽、陳淮、陳中和:慢性完全阻塞性冠狀動脈疾病的氣球擴張術治療法•中華民國心臟學會雜誌,11,122-32,1995。
陳澄鋆、王丹江、謝士明:冠狀動脈氣球導管擴張術•國防醫學,5(4),355-7,1987。
陳逸忠、黃啟宏、陳淮、王榮添、吳俊逸、邱恆正:冠狀動脈血管支架置放後臨床事件發生的頻率•中華民國心臟學會雜誌,16,143-51,2000。
曾春典:經皮冠狀動脈擴張術(PTCA)在冠狀動脈疾病的應用•北市醫誌,37(10),29-36,1993。
程俊傑:冠狀動脈病支架治療新進展—成效與併發症•繼續醫學教育,6(2),127-31,1996。
楊茂勳:冠心病介入性治療及進展•台灣內科醫學會九十年會員大會學術演講論文,2001。
廖朝崧:冠狀動脈病支架治療新進展—未來展望•繼續醫學教育,6(2),136-38,1996。
藍青:血管支架與高科技醫療•健康世界,187,72-76,2001。
鄭乃仁:急性心肌梗塞治療•內科新知,2(2),32-36,1999。
英文部份
Schieber GJ, Poullier JP, and Greenwald LM.(1980-1992),Health System Performance in OECD Countries,Health.
Clifford, R.W.(1995). Morphological findings in the coronary arteries of patients with myocardial ischemia and its myocardial consequences in heart disease and rehabilitation. In Pollock, M.L., & Schmidt, D.H.(eds):Heart Disease and Rehabilitation, 3rd ed. Champaign, I.L., Human Kinetics, pp 19-41
Andersen Aday RM, & Aday LA. Access to medical care in the U.S.: realized and potential. Medical Care 1978; 16(7): 533-546.
Barer ML, Pulcins IR, & Evans RG et al. Trends in use of medical services by the elderly in 1989
Cox C. Physician utilization by three groups of ethnic elderly. Medical Care 1986; 24:667-676.
Dranove D. Rate-setting by DRG and specialization. The Rand Journal of Economics 1987;18:417-427.
Ellis RP, McGuire TG. Supply-side and demand-side cost sharing in health care. Journal of Economic Perspectives 1993; 7(4): 135-151.
Fetter RB, Brand DA, Grmache D. DRGs-their design and development. Michigan: Ann Arbor, 1991.
Fox GN. Resource use by younger versus older patients. The Family Practice Research Journal 1993; 13(3): 283-290.
Kosecoff J, Kanh K, & Rogers E et al. Prospective payment system and impairment atdischarge: the "quicker-and-sicker" story revisited. Journal of the American Medical Association 1990; 264(15): 1980-1983.
Knudtson M.L., Wyse D.G., et al,(2002).Chelation therapy for ischemic heart disease. JAMA,287(4),481.
Leclere FB, Jensen L, & Biddlecom, A E. Health care utilization, family context, andadaptation among immigrants to the United States. Journal of Health and SocialBehavior 1994; 35(4): 370-384.
Menke T. Impacts of PPS on Medicare part B expenditures and utilization for hospital episodes of care. Inquiry 1990; 27: 114-126.
Newhouse. Joseph P.:Medical Care Cost:How Much Welfare Loss?Journal of Ecnomic Perspective, 1992;6(3):3-21.
Newhouse JP. Do unprofitable patients face access problems? Health Care Financing Review 1989; 11(2): 33-42.
Mueller K, Patil K, Boilesen E. The role of uninsurance and race in healthcare utilization by rural minorities. Health services research 1998; 33(3): 597-610.
Munoz E, Sterman H eds. Financial risk and hospital care for elder patients in non-agestratified surgical DRGs. The American Surgeon 1988a; 54(9): 535-538.
Munoz E, Greenberg R eds. Gastroenterology, diagnosis-related groups, and age. Journal of Clinical Gastroenterology 1989; 11(4): 421-429.
Murphy JF, Hepworth JT. Age and gender differences in health services utilization. Research in Nursing & Health 1996; 19: 323-329.
Tierney WM. Fitzgerald JF. Miller ME. James MK. McDonald CJ. Predicting inpatient costs with admitting clinical data. Medical Care. 1995; 33(1): 1-14.
Detre K., Holubkov R., et al, (1989). Follow- up results of the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation,80,421-8.
Goldsmith M.F.(1997). Cardiologists Broaden Use of Stents. JAMA, 277(4),275-276.
http://www.advocatehealth.com
McCorkle L.P.(1996). Utilization of facilities of a university hospital: length of inpatient stay in various hospital department. Health Service Research,1,91-114.
Meads C, Cummins C, Jolly K, Steven A, Burls A, Hyde C.(2000). Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
Rodriguez A., Bernardi V., et al,(1998). In- hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction(GRAMI trail). American Journal of Cardiology, 81,1286-91.
Schatz R.A., Goldbergs M.L., et al,(1991). Clinical experience with the Palmaz-Schatz coronary stent. J Am Coll Cardiol, 17,155B-9B.
Jollis JG, Peterson ED, DeLong ER. The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality. N Engl J Med 1994;331:1625-9.
Moscucci M. Share D. Smith D.et al,Relationship between operator volume and adverse outcome in contemporary percutaneous coronary intervention practice: an analysis of a quality-controlled multicenter percutaneous coronary intervention clinical database. Journal of the American College of Cardiology.2005;46(4):625-32.
Nageh T. Sherwood RA. Harris BM. et al ,Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease. Heart (British Cardiac Society) .2005;91(9):1181-5.
Laskey WK. Selzer F. Jacobs AK.et al ,Importance of the postdischarge interval in assessing major adverse clinical event Rates following percutaneous coronary intervention. American Journal of Cardiology. 2005;95(10):1135-9.
Wohrle J. Grebe OC. Nusser T. et al ,Reduction f major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty. Circulation. 2003;107(14):1840-3.
Rubboli A. Brancaleoni R. Euler DE. et al , Outcome of percutaneous coronary angioplasty (PTCA) performed in a low-volume institution by low-volume operators, evaluated by means of the one-month major adverse cardiac event Rate. Minerva Cardioangiologica. 2001;49(6):357-62.
Steinhubl SR. Talley JD. Braden GA. et al , Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation. 2001;103(21):2572-8.
Lindsay J. Pinnow EE. Pichard AD.,et alFrequency of Major Adverse Cardiac Events Within One Month of Coronary Angioplasty : A Useful Measure of Operator Performance. Journal of the American College of Cardiology.1999;34(7):1916-23. | zh_TW |